NSE BSE
chemo pharma laboratories ltd. stock

CHEMO PHARMA LABORATORIES LTD. Share Price

- - (%)
Sector: -

506365

CHEMOPH

img img img img
No Data Available

CHEMO PHARMA LABORATORIES LTD. Share Price Update


As of the latest trading session, CHEMO PHARMA LABORATORIES LTD. share price is currently at 0, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 0.00 and 0.00. Over the past year, CHEMO PHARMA LABORATORIES LTD. has achieved a return of 121.04 %. In the last month alone, the return has been -2.72 %.

CHEMO PHARMA LABORATORIES LTD. Performance

Day Range

Low.00 High.00
80.68

52 Week Range

Low 27.17 High 87.00
80.68

Open Price

.00

Prev. Close

.00

Volume (Shares)

7.00

Total traded value

.00

Upper Circuit

82.29

Lower Circuit

79.07

Note: The current prices & values are delayed, Login to your account for live updates.

CHEMO PHARMA LABORATORIES LTD. Fundamentals


(Standalone)

Market Cap (Cr) 0.00
PE Ratio (TTM) 9.00
Book Value / Share 82.78
Beta 0.13
ROE 0.43%
EPS (TTM) 8.96
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.68

CHEMO PHARMA LABORATORIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.03
Net Profit 0.68
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 4.51
EBITDA 0.68
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit 0.44
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 2.93
EBITDA 0.44
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.05
Net Profit 0.38
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 2.51
EBITDA 0.38
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit -0.15
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.99
EBITDA -0.12
Effective Tax Rate (%) -25.00
Particulars DEC 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit 0.16
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 1.08
EBITDA 0.16
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.22
Net Profit 0.05
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.32
EBITDA 0.08
Effective Tax Rate (%) 42.85
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.42
Net Profit 0.56
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 3.73
EBITDA 0.38
Effective Tax Rate (%) -55.55
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.36
Net Profit 0.25
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 1.67
EBITDA 0.33
Effective Tax Rate (%) 19.35
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 0.50
Net Profit 0.42
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 2.77
EBITDA 0.51
Effective Tax Rate (%) 16.32
Particulars MAR 2019 (Values in Cr)
Revenue 0.00
Operating Expense 0.57
Net Profit 0.21
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 1.38
EBITDA 0.25
Effective Tax Rate (%) 20.00
Particulars MAR 2016 (Values in Cr)
Book Value / Share 24.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 77.35
ROE % 0.43
ROCE % 0.78
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 77.03
ROE % 3.37
ROCE % 1.33
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 73.30
ROE % 2.30
ROCE % 2.85
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share 71.63
ROE % 3.99
ROCE % 4.75
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2019 (Values in Cr)
Book Value / Share 68.86
ROE % 2.05
ROCE % 2.54
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2016 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 3.86
Total Liabilities 3.86
Total Equity 3.67
Share Outstanding 1500000
Price to Book Ratio 0.50
Return on Assets (%) -37.44
Return on Capital (%) -39.44
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.05
Total Assets 11.62
Total Liabilities 11.62
Total Equity 11.60
Share Outstanding 1500000
Price to Book Ratio 0.52
Return on Assets (%) 0.40
Return on Capital (%) 0.41
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.18
Total Assets 11.66
Total Liabilities 11.66
Total Equity 11.55
Share Outstanding 1500000
Price to Book Ratio 0.54
Return on Assets (%) 4.80
Return on Capital (%) 4.85
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 10.87
Total Assets 11.05
Total Liabilities 11.05
Total Equity 10.99
Share Outstanding 1500000
Price to Book Ratio 0.24
Return on Assets (%) 2.26
Return on Capital (%) 2.27
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 8.80
Total Assets 10.96
Total Liabilities 10.96
Total Equity 10.74
Share Outstanding 1500000
Price to Book Ratio 0.09
Return on Assets (%) 3.78
Return on Capital (%) 3.86
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 2.96
Total Assets 10.42
Total Liabilities 10.42
Total Equity 10.32
Share Outstanding 1500000
Price to Book Ratio 0.15
Return on Assets (%) 1.97
Return on Capital (%) 2
Particulars MAR 2023 (Values in Cr)
Net Income 0.07
Cash from Operations -0.67
Cash from Investing 0.62
Cash from Financing -0.07
Net change in Cash -0.13
Free Cash Flow -0.67
Particulars MAR 2022 (Values in Cr)
Net Income 0.36
Cash from Operations -0.26
Cash from Investing 0.96
Cash from Financing -2.12
Net change in Cash -1.48
Free Cash Flow -0.26
Particulars MAR 2021 (Values in Cr)
Net Income 0.31
Cash from Operations -0.32
Cash from Investing -0.18
Cash from Financing 1.95
Net change in Cash 1.36
Free Cash Flow -0.32
Particulars MAR 2020 (Values in Cr)
Net Income 0.49
Cash from Operations 4.91
Cash from Investing 1.00
Cash from Financing 0.00
Net change in Cash 5.84
Free Cash Flow 4.91
Particulars MAR 2019 (Values in Cr)
Net Income 0.25
Cash from Operations -5.43
Cash from Investing 0.78
Cash from Financing 0.00
Net change in Cash -4.69
Free Cash Flow -5.43
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 110.40 12.07 1.19 1155.79 71.00 / 148.95
CIPLA LTD 1403.90 26.62 4.24 113350.18 913.20 / 1519.00
FERMENTA BIOTECH LIMITED 162.85 0.00 1.67 479.28 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2355.75 57.70 22.44 39907.83 1275.05 / 2649.95
SANOFI INDIA LIMITED 8827.95 35.84 20.02 20330.77 6253.40 / 9370.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
CHEMO PHARMA LABORATORIES LTD. 80.68 9.00 0.97 12.10 27.17 / 87.00
AMRUTAJAN HEALTH LTD 743.15 48.83 8.20 2148.49 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.35 90.24 21.97 14393.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 110.40 15.25 1.16 1155.79 71.00 / 148.95
ABBOTT INDIA LIMITED 26643.70 47.13 15.30 56617.86 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 81.20
  • 26 Days 78.10
  • 10 Days 81.90
  • 50 Days 75.80
  • 12 Days 82.00
  • 100 Days 69.30
  • 20 Days 80.20
  • 200 Days 39.30
80.68
PIVOT
First Resistance 80.68
Second Resistance 80.68
Third Resistance 80.68
First Support 80.68
Second Support 80.68
Third Support 80.68
RSI 56.37
MACD 3.92
Commodity Channel Index (CCI) 5.16
ADX 45.39
Williams % R -53.33

Over 1 Month

down

-2.72

Over 3 Months

down

5.40

Over 6 Months

down

95.35

Over 1 Year

down

121.04

Over 3 Years

down

44.30

Over 5 Years

down

59.48

CHEMO PHARMA LABORATORIES LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

CHEMO PHARMA LABORATORIES LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
72.11
Promoter Holdings
27.88
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Citric India Ltd Shareholding of Promoter and Promoter Group 369500.0 24.63
Shree Consultation And Services Pvt Ltd Public Shareholding 54500.0 3.63
Shanta Somani Shareholding of Promoter and Promoter Group 48781.0 3.25
Ravindra Somani Public Shareholding 47411.0 3.16
Sudhir Harilal Kale Public Shareholding 35000.0 2.33

CHEMO PHARMA LABORATORIES LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About CHEMO PHARMA LABORATORIES LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by CHEMO PHARMA LABORATORIES LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Chemo Pharma Laboratories Ltd?

Answer Field

The share price of Chemo Pharma Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 0.

What is the Market Cap of Chemo Pharma Laboratories Ltd?

Answer Field

The market cap of Chemo Pharma Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 0.00 Cr. as of now.

What is the 52 Week High and Low of Chemo Pharma Laboratories Ltd?

Answer Field

The 52 Week High and Low of Chemo Pharma Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 87.00 and ₹ 27.17.

How to Buy Chemo Pharma Laboratories Ltd share?

Answer Field

You can trade in Chemo Pharma Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Chemo Pharma Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 121.04%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader